Clifford Talbert
Interventional Cardiology · Cape Girardeau, MONPI 1598700338
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,901 and has fallen 93.8% since, to $117 in 2025. That places this record below the midpoint for interventional cardiology clinicians in MO, where the typical reported total is $10,448.
Across 161 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$572
- Amgen$471
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$304
- Novartis$251
- Pfizer$218
- Edwards Lifesciences$193
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,06099%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 37 | $572 |
| Amgen | 22 | $471 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $304 |
| Novartis | 23 | $251 |
| Pfizer | 18 | $218 |
| Edwards Lifesciences | 1 | $193 |
| Chiesi USA, Inc. | 2 | $181 |
| AstraZeneca | 2 | $143 |
| Boehringer Ingelheim | 9 | $141 |
| E.r. Squibb & Sons, L.L.C. | 4 | $133 |
| Bridgebio Pharma, Inc. | 1 | $117 |
| Lundbeck LLC | 5 | $96 |
| Regeneron Healthcare Solutions, Inc. | 5 | $67 |
| Amarin Pharma, Inc. | 5 | $63 |
| Medtronic | 3 | $34 |
| Boston Scientific | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Akcea Therapeutics, Inc. | 1 | $23 |
| Irhythm Technologies, Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$193
- KENGREAL$126
- BREZTRI$120
- LifeVest$118
- Attruby$117
How this compares
$3,105 in reported general payments places this provider in the 20th percentile of 182 interventional cardiology providers in Missouri.
Other interventional cardiology in Cape Girardeau
- Duc NguyenCape Girardeau$21K
- Joshua StolkerWashington$1.2M
- John LasalaSaint Louis$936K
- Harvey SerotaSaint Louis$752K
- Jasvindar SinghSaint Louis$696K
- Gerald MancusoKansas City$402K
- James GranthamKansas City$357K
- Matthew BunteKansas City$242K
- Alan ZajariasSaint Louis$203K
- Anish ThomasSaint Louis$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.